Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)

TYO:4596 Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-1,249	-1,332	-1,489	-2,015	-2,616	-2,437
Depreciation & Amortization	51.03	65	87	58	59	45
Loss (Gain) From Sale of Assets	52.67	113	112	-2	-	-
Loss (Gain) From Sale of Investments	-	-	-	-1	2	-4
Stock-Based Compensation	25.68	-	-	-	-	-
Other Operating Activities	-4.21	-6	-13	-19	-11	-69
Change in Accounts Receivable	-4.15	-2	1	-3	-	-
Change in Accounts Payable	-37.21	-104	-113	-247	57	49
Change in Other Net Operating Assets	-38.31	71	80	143	-4	168
Operating Cash Flow	-1,126	-1,195	-1,335	-2,086	-2,513	-2,248
Capital Expenditures	-48.14	-49	-66	-57	-8	-13
Other Investing Activities	9.89	6	21	562	3,570	353
Investing Cash Flow	-38.25	-43	-45	505	3,562	340
Issuance of Common Stock	105.73	48	148	1,514	319	597
Other Financing Activities	-	-136	-52	-68	-148	-144
Financing Cash Flow	-22.79	-88	96	1,446	171	453
Foreign Exchange Rate Adjustments	-2.85	13	3	206	223	-204
Miscellaneous Cash Flow Adjustments	-	1	-	-	-	1
Net Cash Flow	-1,190	-1,312	-1,281	71	1,443	-1,658
Free Cash Flow	-1,174	-1,244	-1,401	-2,143	-2,521	-2,261
Free Cash Flow Margin	-3993.29%	-4607.41%	-3592.31%	-26787.50%	-	-6110.81%
Free Cash Flow Per Share	-20.71	-22.08	-25.20	-43.50	-55.36	-52.78
Cash Interest Paid	5.69	7	9	11	18	16
Levered Free Cash Flow	-813.66	-820	-987.63	-969.25	1,736	-1,472
Unlevered Free Cash Flow	-810.13	-815.63	-982	-962.38	1,748	-1,462
Change in Net Working Capital	82.25	61	63	-356	-3,349	-95

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.